Pulmonary embolism: update on diagnosis and management

Area of Science:

• Cardiology
• Radiology
• Pharmacology

Background:

• Pulmonary embolism (PE) is a critical condition requiring prompt diagnosis and treatment.
• Non-specific symptoms necessitate objective diagnostic tools.
• Clinical decision rules aid in assessing PE pre-test probability.

Purpose of the Study:

• To outline diagnostic pathways for pulmonary embolism.
• To compare imaging modalities for PE detection.
• To review current anticoagulation strategies for PE management.

Main Methods:

• Utilizing clinical assessment and decision rules to stratify PE risk.
• Employing D-dimer testing for unlikely PE cases.
• Comparing computed tomography pulmonary angiogram (CTPA) and ventilation-perfusion (VQ) scans for diagnosis.
• Evaluating direct oral anticoagulants (DOACs) versus traditional anticoagulants.

Main Results:

• D-dimer testing can exclude PE if negative; positive results warrant imaging.
• CTPA is accurate but may find incidental findings; VQ scans offer lower radiation exposure.
• VQ scans are useful for low/high probability cases, but intermediate results need further investigation.
• DOACs offer advantages over vitamin K antagonists, including lower bleeding risk and easier administration, though initial parenteral treatment is sometimes needed.

Conclusions:

• A structured diagnostic approach combining clinical judgment, D-dimer, and appropriate imaging is crucial for PE.
• DOACs represent a significant advancement in PE anticoagulation therapy.
• Individualized treatment decisions consider patient factors, diagnostic findings, and therapeutic options.